DC
HRTX icon

Deere & Company’s Heron Therapeutics HRTX Stock Holding History

Deere & Company’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-17,926
Closed -$479K – 1068
2015
Q4 		$479K Buy
+17,926
New +$479K 0.03% 573
2015
Q3 		– Sell
-18,698
Closed -$583K – 982
2015
Q2 		$583K Buy
18,698
+3,825
+26% +$72K 0.03% 575
2015
Q1 		$216K Buy
+14,873
New +$168K 0.01% 854

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deere & Company's HRTX Position: Q1 2016 in Review

Deere & Company sold out of Heron Therapeutics (HRTX) in Q1 2016, closing a stake of 17,926 shares — an estimated $479K sold.

Deere & Company first reported a position in HRTX in Q1 2015 and held it in 3 quarters. The position peaked at $583K in Q2 2015. 99 funds tracked by Wall St. Rank hold HRTX as of Q1 2016.

  • Deere & Company reported no remaining Heron Therapeutics position as of Q1 2016 after selling out during the quarter.
  • Deere & Company sold 17,926 Heron Therapeutics shares in Q1 2016, an estimated $479K.
  • Deere & Company first reported a position in Heron Therapeutics in Q1 2015 and held it in 3 quarters.
  • Deere & Company's Heron Therapeutics position peaked at $583K in Q2 2015.
  • 99 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2016.

Based on Deere & Company's 13F filing for Q1 2016, filed 9 May 2016.